NICE conditionally recommends 5 promising technologies for Parkinson's disease
These promising technologies could help improve symptoms and quality of life for people with Parkinson’s disease.
These promising technologies could help improve symptoms and quality of life for people with Parkinson’s disease.
New NICE non-executive director appointment approved by the Secretary of State for Health and Social Care
A life-extending drug combination for some people with advanced breast cancer will now be available for routine use in the NHS.
Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab, a drug that reduces the chance of it returning.
Up to 500 people each year could be treated using faecal microbiota transplant for multiple recurrences of Clostridium difficile infections.
NICE publishes first draft guidance from its Early Value Assessment pilot project recommending smartphone-linked ECG device
Page 28 of 39